Cambridge, Mass., Officials OK Life Science Complex | GenomeWeb

This story was originally posted June 4, and updated later that day to include additional information on the project and comment from Alexandria Real Estate Equities' Tom Andrews.

By Alex Philippidis

NEW YORK (GenomeWeb News) — Alexandria Real Estate Equities has won approval from the Planning Board of Cambridge, Mass., to develop a $1 billion, 1.7 million-square-foot complex of office/laboratory space and other uses set to rise over the next several years in the city's East Cambridge section near Kendall Square.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.